Funded Tech Companies
SRTD biotech
Wondering who provided funding to SRTD biotech? Lilly Ventures, Boehringer Ingelheim Venture Fund and Mérieux Equity Partners invested in this life sciences company.
Company Overview
Company Name
SRTD biotech
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Huthmacherstrasse 20
Jülich, 52428
Germany
Jülich, 52428
Germany
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
We are developing the first pro-drug platform on RNA level, targeting oncological, viral and genetic diseases. It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed RNAs (seRNAs) to patients. We have an ambitious pipeline that targets indications of highest medical need. Many devastating diseases cannot be effectively treated. Even if therapies exist, often they don't specifically target the diseased area, leading to a high risk of severe side effects. To overcome this inherent problem, we have developed seRNA as a new RNA-based therapy approach.
Last Transaction
11/9/2026
Financing History
Management Team
Title
Name
Email & Social
Company Investors
- Lilly Ventures
- Boehringer Ingelheim Venture Fund
- Mérieux Equity Partners
- High-Tech Gründerfonds
- NRW.BANK
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs








